Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB(1) cannabinoid receptor ligands and potential antagonists: synthesis, lipophilicity, affinity, and molecular modeling.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples